IDBS said this week that King's Health Partners has deployed its Oncology Research Information System to manage breast cancer data from multiple sites.
According to IDBS, the platform will allow KHP to combine clinical, genetic, and tissue sample data from more than 26,000 breast cancer patients as well as incorporate data from newly consented patients.
Peter Parker, who heads the cancer studies division and is also the research and development lead for the Integrated Cancer Center at KHP, said that the platform will help the hospital "better understand the complex causes and molecular basis of cancer" by enabling clinicians to make "better use of patient data."
IDBS' ORIS is an informatics platform for examining clinical, diagnostic, pathological, biopsy, research, and genomics data. It pulls in information from multiple sources including an internal cancer information system, electronic patient records, diagnostic imaging, and breast pathology data.
The platform also includes disease ontologies and terminology mapping, which support clinical data standards including ICD-10. All patient data is de-identified in the secure system and made available to genomic analysis applications for patient outcomes and clustering.
ORIS can also be used by pharmaceutical, biotechnology, and diagnostic companies looking to form research collaborations focused on cancer. It can be used to identify patient cohorts — based on similar disease characteristics — whose treatment, genetic profiles, and outcomes can be followed.
ORIS is part of a larger nine-year partnership between IDBS and KHP announced last year that aims to use patients' genomic and clinical profiles to develop individualized cancer therapies (BI 03/11/2011).